Podcast
Questions and Answers
In a study comparing a treatment group to a control group, what does a Relative Risk (RR) of 2 for acute renal failure (ARF) indicate?
In a study comparing a treatment group to a control group, what does a Relative Risk (RR) of 2 for acute renal failure (ARF) indicate?
- The treatment doubles the risk of ARF compared to the control. (correct)
- The treatment decreases the risk of ARF by 2%.
- The treatment has no impact on the risk of ARF.
- The treatment halves the risk of ARF compared to the control.
If a treatment for a disease has a Number Needed to Harm (NNH) of 100, what is the correct interpretation?
If a treatment for a disease has a Number Needed to Harm (NNH) of 100, what is the correct interpretation?
- 100 patients need to be treated for 1 to experience a harmful side effect. (correct)
- 100 patients need to be treated for 1 to benefit.
- 1 patient will be cured out of 100 treated.
- The treatment is effective in 1 out of every 10 patients.
If the risk of a certain cancer in the general population is 10%, but increases to 70% with a specific genetic mutation, what is the Attributable Risk (ATR) of the mutation?
If the risk of a certain cancer in the general population is 10%, but increases to 70% with a specific genetic mutation, what is the Attributable Risk (ATR) of the mutation?
- 60% (correct)
- 10%
- 70%
- 80%
In the context of medical statistics, what does a Risk Ratio (RR) equal to 1 imply?
In the context of medical statistics, what does a Risk Ratio (RR) equal to 1 imply?
When is the Odds Ratio (OR) most appropriately used rather than the Risk Ratio (RR)?
When is the Odds Ratio (OR) most appropriately used rather than the Risk Ratio (RR)?
What does an Odds Ratio greater than 1 suggest?
What does an Odds Ratio greater than 1 suggest?
How is the Odds Ratio calculated in a typical 2x2 contingency table?
How is the Odds Ratio calculated in a typical 2x2 contingency table?
What limitation is shared by both Relative Risk (RR) and Odds Ratio (OR) measures?
What limitation is shared by both Relative Risk (RR) and Odds Ratio (OR) measures?
In a clinical trial, the control group has a disease incidence rate of 5%, while the treatment group has a rate of 1%. What is the Relative Risk Reduction (RRR)?
In a clinical trial, the control group has a disease incidence rate of 5%, while the treatment group has a rate of 1%. What is the Relative Risk Reduction (RRR)?
A screening test for a rare disease has a sensitivity of 95% and a specificity of 90%. If 1,000 people are screened and the true prevalence of the disease is 1%, how many false positives would you expect?
A screening test for a rare disease has a sensitivity of 95% and a specificity of 90%. If 1,000 people are screened and the true prevalence of the disease is 1%, how many false positives would you expect?
In clinical trials, what scenario would result in the largest difference between relative risk reduction (RRR) and absolute risk reduction (ARR)?
In clinical trials, what scenario would result in the largest difference between relative risk reduction (RRR) and absolute risk reduction (ARR)?
A new cancer drug extends the median survival time by 3 months, but the 5-year survival rate remains unchanged. What is the most appropriate conclusion?
A new cancer drug extends the median survival time by 3 months, but the 5-year survival rate remains unchanged. What is the most appropriate conclusion?
In a clinical trial, a drug reduces the relative risk of a disease by 25%. Which statement accurately interprets this finding?
In a clinical trial, a drug reduces the relative risk of a disease by 25%. Which statement accurately interprets this finding?
A study reports a new treatment for a rare disease with a high relative risk reduction (RRR) but a very high number needed to treat (NNT). What is the most important consideration when interpreting these results?
A study reports a new treatment for a rare disease with a high relative risk reduction (RRR) but a very high number needed to treat (NNT). What is the most important consideration when interpreting these results?
A researcher discovers a new biomarker that strongly correlates with disease progression. What is the most critical next step to validate its clinical utility?
A researcher discovers a new biomarker that strongly correlates with disease progression. What is the most critical next step to validate its clinical utility?
In the calculation of the Number Needed to Treat (NNT), what is the correct interpretation of a very low NNT (e.g., NNT = 2)?
In the calculation of the Number Needed to Treat (NNT), what is the correct interpretation of a very low NNT (e.g., NNT = 2)?
A study reports that a new drug decreases the rate of heart attacks by 50% (RRR) in a group of patients. Which additional piece of information is most crucial for assessing the clinical significance of this finding?
A study reports that a new drug decreases the rate of heart attacks by 50% (RRR) in a group of patients. Which additional piece of information is most crucial for assessing the clinical significance of this finding?
In a randomized controlled trial, a treatment shows a statistically significant relative risk reduction but no significant absolute risk reduction. What methodological issue might explain this discrepancy?
In a randomized controlled trial, a treatment shows a statistically significant relative risk reduction but no significant absolute risk reduction. What methodological issue might explain this discrepancy?
What inherent limitation exists when using '5-year disease-free survival' as the primary endpoint in cancer clinical trials?
What inherent limitation exists when using '5-year disease-free survival' as the primary endpoint in cancer clinical trials?
A new diagnostic test for a rare disease has a sensitivity of 99% and a specificity of 99%. What is the most important consideration when interpreting the predictive value of a positive test in a low-prevalence population?
A new diagnostic test for a rare disease has a sensitivity of 99% and a specificity of 99%. What is the most important consideration when interpreting the predictive value of a positive test in a low-prevalence population?
Which of the following accurately describes the use of the Case-Fatality Rate (CFR)?
Which of the following accurately describes the use of the Case-Fatality Rate (CFR)?
How does the median survival time offer an advantage over the mean survival time in prognostic studies?
How does the median survival time offer an advantage over the mean survival time in prognostic studies?
In the context of prognosis, what fundamental role do risk factors play?
In the context of prognosis, what fundamental role do risk factors play?
What best describes the calculation and interpretation of survival probability, as represented in a Kaplan-Meier curve?
What best describes the calculation and interpretation of survival probability, as represented in a Kaplan-Meier curve?
What signifies the critical importance of defining the term 'prognosis'?
What signifies the critical importance of defining the term 'prognosis'?
A new, highly contagious disease emerges with a CFR of 15%. What inference can be made from this statistic?
A new, highly contagious disease emerges with a CFR of 15%. What inference can be made from this statistic?
Which scenario exemplifies the use of morbidity data as described?
Which scenario exemplifies the use of morbidity data as described?
Which scenario most accurately illustrates the relationship between morbidity and mortality measures?
Which scenario most accurately illustrates the relationship between morbidity and mortality measures?
In the context of calculating prognosis, what is the significance of establishing it after diagnosis but before initiating the treatment plan?
In the context of calculating prognosis, what is the significance of establishing it after diagnosis but before initiating the treatment plan?
A study uses a Kaplan-Meier curve to analyze patient survival after a new cancer treatment. If the curve shows a steep decline in the initial months followed by a plateau, what does this suggest about the treatment's effectiveness?
A study uses a Kaplan-Meier curve to analyze patient survival after a new cancer treatment. If the curve shows a steep decline in the initial months followed by a plateau, what does this suggest about the treatment's effectiveness?
Flashcards
Morbidity
Morbidity
Any departure from physiological or psychological well-being; includes disease, injury, and disability.
Mortality
Mortality
Death; a measure of the frequency of death in a population over a time period.
Prognosis
Prognosis
A prediction of the course, duration, and outcome of a disease.
Case-Fatality Rate (CFR)
Case-Fatality Rate (CFR)
Signup and view all the flashcards
Kaplan-Meier Curve
Kaplan-Meier Curve
Signup and view all the flashcards
Median Survival Time
Median Survival Time
Signup and view all the flashcards
Survival Rate
Survival Rate
Signup and view all the flashcards
Survival probability
Survival probability
Signup and view all the flashcards
When is CFR often used?
When is CFR often used?
Signup and view all the flashcards
Mortality rate
Mortality rate
Signup and view all the flashcards
Disease-Free Survival
Disease-Free Survival
Signup and view all the flashcards
Relative Risk Reduction (RRR)
Relative Risk Reduction (RRR)
Signup and view all the flashcards
Absolute Risk Reduction (ARR)
Absolute Risk Reduction (ARR)
Signup and view all the flashcards
Number Needed to Treat (NNT)
Number Needed to Treat (NNT)
Signup and view all the flashcards
Relative Risk (RR)
Relative Risk (RR)
Signup and view all the flashcards
Calculating Relative Risk
Calculating Relative Risk
Signup and view all the flashcards
Calculating RRR
Calculating RRR
Signup and view all the flashcards
Calculating ARR
Calculating ARR
Signup and view all the flashcards
Calculating NNT
Calculating NNT
Signup and view all the flashcards
Attributable Risk (ATR)
Attributable Risk (ATR)
Signup and view all the flashcards
RR = 1
RR = 1
Signup and view all the flashcards
RR > 1
RR > 1
Signup and view all the flashcards
RR < 1
RR < 1
Signup and view all the flashcards
Odds Ratio (OR)
Odds Ratio (OR)
Signup and view all the flashcards
OR = 1
OR = 1
Signup and view all the flashcards
OR > 1
OR > 1
Signup and view all the flashcards
OR < 1
OR < 1
Signup and view all the flashcards
RR and OR Limitations
RR and OR Limitations
Signup and view all the flashcards
Study Notes
- Objectives:
- Define prognosis, morbidity, and mortality
- Describe ways to express prognosis
- Demonstrate proficiency in calculating risk estimates (RRR, ARR, & NNT)
- Understand the difference between Risk Ratio and Odds Ratio and their calculations
Morbidity
- CDC defines morbidity as any departure, subjective or objective, from a state of physiological or psychological well-being, including disease, injury, and disability.
- Morbidity refers to the the number or persons who are ill, illness periods, or illness durations.
- Data comes from disease registries and morbidity surveys like NHANES and the Framingham Heart Study.
Mortality
- CDC defines mortality as death, and mortality rate as the frequency of death in a defined population during a specified interval.
- Morbidity and mortality measures are often mathematically similar, differing by what is being measured (illness or death).
- Data sources: Death certificates, hospital records, and autopsy data.
Frequently Used Measures of Morbidity
- Incidence proportion (attack rate/risk): new cases of disease during a specified time interval/population at the start of the time interval.
- Secondary attack rate: number of new cases among contacts/total number of contacts.
- Incidence rate (person-time rate): number of new cases of disease during a specified time interval/summed person-years of observation or average population during time interval.
- Point prevalence: number of current cases (new and preexisting) at a specified point in time/population at the same specified point in time.
- Period prevalence: number of current cases (new and preexisting) over a specified period of time/average or mid-interval population.
Frequently Used Measures of Mortality
- Crude death rate: total deaths during a given time interval/mid-interval population.
- Cause-specific death rate: deaths assigned to a specific cause during a given time interval/mid-interval population.
- Proportionate mortality: deaths due to a specific cause during a given time interval/total deaths from all causes during the same time interval.
- Death-to-case ratio: deaths assigned to a specific cause during a given time interval/new cases of same disease reported during the same time interval.
- Neonatal mortality rate: deaths among children < 28 days during a given time interval/live births during the same time interval.
- Postneonatal mortality rate: deaths among children 28-364 days during a given time interval/live births during the same time interval.
- Infant mortality rate: deaths among children < 1 year during a given time interval/live births during the same time interval
- Maternal mortality rate: deaths assigned to pregnancy-related causes during a given time interval/live births during the same time interval.
Prognosis
- Prognosis predicts a disease's course, duration, and outcome based on its pathogenesis and risk factors.
- Prognosis is established after diagnosis and before the treatment plan.
- Case-Fatality Rate (CFR): (# of people who die from the disease)/(# of people with the disease) = %
- It's often used for acute diseases of short duration.
- In chronic disease, death may occur long after diagnosis making the possibility of death due to another cause more likely.
- Example: The SARS 2003 Epidemic lasted from February to June, with 8098 cases reported and 774 deaths
- CFR = 774/8098 = 9.6%
Kaplan-Meier Curve
- Identifies the exact time an event (death or lost to follow up) occurs.
- Graphic representation of an event's probability over time, demonstrating survival probability = 1 – (event probability).
Survival
- Median Survival Time: The duration time when half the study population is still surviving.
- This has advantages over mean survival:
- It's less affected by extremes (outliers).
- It can be calculated before the end.
- Survival Rate: represents % of people alive at a certain time after diagnosis
- Ex: 5 Year, Disease-free, Progression-free
- Influenced by type of cancer, stage, age and time for cancer cases.
Relative Risk (RR)
- RR = (Event Rate in Intervention Group) / (Event Rate in Control Group)
- Relative Risk Reduction (RRR) = 1 - relative risk, or (Absolute Risk Reduction) / (Event rate in control group)
- Absolute Risk Reduction (ARR) = (Event rate in control group) - (Event rate in intervention group)
- Number Needed to Treat (NNT) = 1 / (absolute risk reduction)
- Relative risk reduction is often more impressive than absolute risk. The lower the event rate in the control group, the larger the difference between relative risk reduction and absolute risk reduction.
Benefit and Harm Table
-
Number Needed to Treat: number of patients who would need to receive treatment for one to benefit
- calculated as 100 divided by the absolute risk reduction expressed as a percentage (or 1 divided by the absolute risk reduction expressed as a proportion)
-
Number Needed to Harm: number of patients that would have to receive the treatment for one of them to experience an adverse effect
- calculated by 100 divided by the absolute risk increase expressed as a percentage (or 1 divided by the absolute risk increase expressed as a proportion)
Examples of Calculations
-
A new drug decreases the Heart Attack rate by 50%
- 2000 women, ages 30-35 who are non-smokers and w/ no other medical problems are randomized to receive this new drug, then followed for 6 months.
- Rate of MI:
- Control Group 2/1000
- Treatment Group 1/1000
- RR = (1/1000)/(2/1000) = 0.5
- RRR = 1 - 0.5 = 0.5 = 50% Relative Risk Reduction
- ARR = 0.002 - 0.001 = 0.001 = 0.1% Absolute Risk Reduction
- NNT = 1/ARR = 1/0.001 = 1000
- Need to treat 1000 patients to prevent one MI
-
A group of 2000 men, ages 60-65 with hypertension and hyperlipidemia are randomized to receive this new drug, then followed for 12 months.
- Rate of MI:
- Control Group 60/1000
- Treatment Group 30/1000
- RR = (30/1000)/(60/1000) = 0.5
- RRR = 1 - 0.5 = 0.5 = 50% Relative Risk Reduction
- ARR = 0.06 - 0.03 = 0.03 = 3% Absolute Risk Reduction
- NNT = 1/ARR = 1/0.03 = 33
- Need to treat 33 patients to prevent one MI.
- Rate of MI:
-
The drug has a potential side effect of causing acute renal failure. Among the men randomized above, over 12 months the rate of acute renal failure was
- ARF:
- Control Group 10/1000
- Treatment Group 20/1000
- RR = 2
- Relative Risk Increase 100%
- ARI = 0.01 = 1%
- NNH = 1/0.01 = 100
- If you treat 100 patients, 1 will develop acute renal faliure.
- ARF:
Attributable Risk (ATR)
- ATR is the risk difference between exposed and unexposed groups.
- For example, the risk of breast cancer in the general population is about 13%. The risk is about 60% if a person has the BRCA1 gene mutation.
- ATR = 60% - 13% = 47% = 0.47
Risk Ratio
- Compares probabilities in two groups, also known as the risk ratio; ratio of two conditional probabilities.
- An RR = 1 implies the event is equally probable in both groups.
- An RR > 1 implies that the event is more likely in the first group, and an RR < 1 implies that the event is less likely in the first group.
- Often used for RCT and cohort studies.
- RR = a/(a+b) / c/(c+d)
Odds Ratio
- Compares the probability of an event between 2 groups.
- An odds ratio of 1 implies that the event is equally likely in both groups.
- An odds ratio greater than one implies that the event is more likely in the first group.
- An odds ratio less than one implies that the event is less likely in the first group.
- Often used for case-control studies, because the total denominator for the entire population is unknown.
- OR = a/b / c/d
- Which can be simplified to OR = ad/bc
- If the odds are the same in each row, then the odds ratio is 1.
Additional Points for Risk Ratio and Odds Ratio
- These measures do not indicate the absolute probability that someone exposed to the risk factor will develop the disease.
- If the frequency of a disease is 2/million in the exposed group, but 1/million in the unexposed, RR is doubled by exposure if the groups are of equal size. However, the disease is still rare in both groups.
- For uncommon events (e.g., frequency < 10% of the population), the values of RR and OR are nearly the same.
- For common events, the OR may increase disproportionately while that of RR is constrained. OR is always further away from 1 than RR. If exposure increases risk, then OR > RR > 1.
- RR or OR should be presented with the corresponding 95% confidence interval (CI). If both the lower and upper confidence limits are > 1, than the exposure increases the risk. If both limits are < 1, then the exposure is protective. However, if the confidence interval includes 1, then you cannot conclude either way.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.